Sterile, high-purity bacteriostatic water
Combination therapies Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists offers a promising approach to enhance cardiovascular and kidney protection in people with type 2 diabetes mellitus, particularly those at high risk [9,20]
This can lead to small intestinal bacterial overgrowth (SIBO), altered fermentation patterns, and changes in metabolite production that affect everything from mood to immune function
Ready-to-drink shakes from brands like Abbotts Ensure formulated with protein, prebiotic fibre, and vitamins provide nutritional intake for the growing cohorts of older adults and GLP-1 users
Microinjection of a SP receptor antagonist into the amygdala was anxiolytic, where SP was anxiogenic (Ebner et al., 2004